| scholarly article | Q13442814 |
| P50 | author | Luz M Suarez | Q64976877 |
| Samuel Alberquilla | Q87888153 | ||
| Jose R García-Montes | Q87888157 | ||
| Rosario Moratalla | Q38329789 | ||
| P2093 | author name string | Samuel Alberquilla | |
| Jose R García-Montes | |||
| Luz M Suarez | |||
| P2860 | cites work | Synaptic organisation of the basal ganglia | Q24544917 |
| Genetics of Parkinson's disease | Q26827825 | ||
| Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3 | Q28245895 | ||
| The transcription factor PITX3 is associated with sporadic Parkinson's disease | Q28251266 | ||
| Subregional, dendritic compartment, and spine subtype specificity in cocaine regulation of dendritic spines in the nucleus accumbens | Q28266784 | ||
| Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images | Q28755127 | ||
| The self-tuning neuron: synaptic scaling of excitatory synapses | Q29616059 | ||
| The functional anatomy of basal ganglia disorders | Q29617461 | ||
| Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease | Q30484170 | ||
| Dopamine-dependent motor learning: insight into levodopa's long-duration response. | Q30502109 | ||
| Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice | Q30538394 | ||
| Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia | Q30650489 | ||
| Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey | Q32061819 | ||
| Evidence of a breakdown of corticostriatal connections in Parkinson's disease. | Q33214147 | ||
| Differential excitability and modulation of striatal medium spiny neuron dendrites | Q33382961 | ||
| Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion | Q33500170 | ||
| Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss | Q34116613 | ||
| Meta-analysis of association between PITX3 gene polymorphism and Parkinson's disease | Q34201863 | ||
| Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations. | Q34313353 | ||
| Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine | Q34613020 | ||
| Pitx3 is required for development of substantia nigra dopaminergic neurons. | Q34923416 | ||
| Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia | Q35574934 | ||
| Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 | ||
| Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons | Q36169973 | ||
| Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice | Q36271380 | ||
| Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease | Q36296271 | ||
| Modulation of striatal projection systems by dopamine | Q36367283 | ||
| Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. | Q36611489 | ||
| Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism | Q36763909 | ||
| Isolation of a new homeobox gene belonging to the Pitx/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19. | Q36885746 | ||
| Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum | Q48280361 | ||
| L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function. | Q48432859 | ||
| Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease | Q48923652 | ||
| Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease | Q49069694 | ||
| Dopamine Depletion Impairs Bilateral Sensory Processing in the Striatum in a Pathway-Dependent Manner. | Q50994519 | ||
| Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease | Q68502274 | ||
| Heterogeneity of metabotropic glutamate receptors in the striatum: electrophysiological evidence | Q72691601 | ||
| PITX3 polymorphism is not associated with Parkinson's disease in a Chinese population | Q82256696 | ||
| Association between PITX3 promoter polymorphism and risk of Parkinson's disease: the impact of ethnicity and onset age | Q87043213 | ||
| Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease | Q36996302 | ||
| Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses | Q37048087 | ||
| Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation | Q37080018 | ||
| Balancing structure and function at hippocampal dendritic spines | Q37088448 | ||
| Global actions of nicotine on the striatal microcircuit. | Q37282375 | ||
| L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia | Q37344222 | ||
| Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice | Q37609566 | ||
| Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation. | Q37925513 | ||
| Animal models of L-DOPA-induced dyskinesia: an update on the current options | Q37998775 | ||
| PITX3 and risk for Parkinson's disease: a systematic review and meta-analysis. | Q38187820 | ||
| Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. | Q38309143 | ||
| Local and afferent synaptic pathways in the striatal microcircuitry | Q38519415 | ||
| Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity? | Q38766091 | ||
| Pathophysiological signatures of functional connectomics in parkinsonian and dyskinetic striatal microcircuits | Q38898527 | ||
| Synaptic functions of endocannabinoid signaling in health and disease | Q39381131 | ||
| Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease. | Q39735904 | ||
| MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. | Q40817289 | ||
| Neostriatal cell subtypes and their functional roles | Q41412474 | ||
| L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. | Q42440010 | ||
| Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice | Q42466609 | ||
| Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP. | Q42483926 | ||
| Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism | Q42484046 | ||
| Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control | Q42484851 | ||
| Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease | Q42497576 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors | Q42517796 | ||
| Target selectivity of feedforward inhibition by striatal fast-spiking interneurons. | Q42519756 | ||
| Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization | Q44407165 | ||
| Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons | Q44408466 | ||
| Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 | ||
| Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice. | Q44777361 | ||
| 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. | Q45281160 | ||
| Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. | Q45972521 | ||
| Transcription factor PITX3 gene in Parkinson's disease | Q46097955 | ||
| Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. | Q46608469 | ||
| PITX3 polymorphism is associated with early onset Parkinson's disease | Q46638690 | ||
| ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice | Q46684571 | ||
| Differential tonic GABA conductances in striatal medium spiny neurons | Q46782245 | ||
| Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling | Q47637177 | ||
| Levodopa treatment and dendritic spine pathology | Q48113066 | ||
| Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia | Q48124096 | ||
| Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. | Q48234700 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | striatum | Q1319792 |
| P304 | page(s) | 3619-3630 | |
| P577 | publication date | 2018-02-26 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease | |
| P478 | volume | 38 |
| Q64251973 | Delayed Spine Pruning of Direct Pathway Spiny Projection Neurons in a Mouse Model of Parkinson's Disease |
| Q90597369 | Dopamine Triggers the Maturation of Striatal Spiny Projection Neuron Excitability during a Critical Period |
| Q92773981 | Dopaminergic modulation of striatal function and Parkinson's disease |
| Q58603118 | Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin |
| Q88498846 | On the neuronal circuitry mediating L-DOPA-induced dyskinesia |
| Q100418590 | Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations |
| Q64086843 | Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease |
| Q89208062 | Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice |
| Q55546568 | Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. |
Search more.